Perioperative management of Glanzmann's syndrome: how we did it!

Thrombasthenia Glanzmann, named after the Swiss paediatrician Eduard Glanzmann (1887-1959), is a rare disease of platelet dysfunction. This disease is characterized by a deficiency or defect of the fibrinogen receptor (GPIIb-IIIa) on the platelet surface. The GPIIb-IIIa receptor has an essential function in the adhesion and aggregation of the platelets. The platelets of these patients cannot bind fibrinogen and aggregation does not occur. Patients have a severe lifelong risk of bleeding, especially during surgical procedures. These patients require a special perioperative regimen for an adequate function of the coagulation system to prevent intraoperative and postoperative bleeding. In this study, we present the perioperative management of a patient with thrombasthenia Glanzmann during elective inguinal hernia repair.

[1]  R. Saxena,et al.  Glanzmann's Thrombasthenia: An Overview , 2009, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[2]  S. Watson,et al.  A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO , 2006, British journal of haematology.

[3]  G. Sottilotta,et al.  Recombinant Activated Factor VII Combined with Desmopressin in Preventing Bleeding from Dental Extraction in a Patient with Glanzmann’s Thrombasthenia , 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[4]  A. Eroğlu,et al.  A Patient with Glanzmann’s Thrombasthenia for Emergent Abdominal Surgery , 2004, Anesthesia and analgesia.

[5]  R. Aster,et al.  Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. , 2002, Blood.

[6]  D. Mohanty,et al.  Glanzmann's thrombasthenia: updated , 2002, Platelets.

[7]  M. Poon.  Use of recombinant factor VIIa in hereditary bleeding disorders , 2001, Current opinion in hematology.

[8]  P. Nurden,et al.  Use of Recombinant Factor VIIa in 3 Patients with Inherited Type I Glanzmann’s Thrombasthenia Undergoing Invasive Procedures , 2000, Thrombosis and Haemostasis.

[9]  D. French,et al.  Hematologically important mutations: Glanzmann thrombasthenia. , 1997, Blood cells, molecules & diseases.

[10]  S. Vučković.  Glanzmann's thrombasthenia revisited. , 1996, The Journal of emergency medicine.

[11]  V. Kudryk,et al.  Dental considerations for a Glanzmann's thrombasthenia patient: case report. , 1996, Journal of periodontology.

[12]  J. George,et al.  Glanzmann's thrombasthenia: the spectrum of clinical disease. , 1990, Blood.

[13]  M. Boiron,et al.  Complete correction of Glanzmann's thrombasthenia by allogeneic bone‐marrow transplantation , 1985, British journal of haematology.

[14]  R. Zotz,et al.  Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents. , 2006, Seminars in hematology.